Systematic reviews,
done right and on time.
AI-assisted screening, extraction, and risk of bias — from first import to PRISMA-ready export. Every decision human-confirmed. Every step auditable.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
INCLUDELincoff AM et al. · N Engl J Med · 2023
A multicenter, double-blind, randomized, placebo-controlled trial evaluating the effect of once-weekly subcutaneous semaglutide 2.4 mg on major adverse cardiovascular events in adults with preexisting cardiovascular disease and a body-mass index of 27 or higher but without diabetes…
AI rationale:RCT in adults with established CVD and BMI ≥27 on semaglutide (GLP-1 RA) with MACE primary outcome and 40-month follow-up — meets all inclusion criteria.
60–80%
Reduction in screening time
AI pre-screens every abstract. You confirm.
100%
Human-confirmed decisions
Every AI output requires your sign-off before export.
PRISMA 2020
Flow diagram auto-generated
SVG download ready for manuscript submission.
Everything the Workflow Requires
From first import to final PRISMA diagram — without switching tools, rebuilding spreadsheets, or losing the audit trail.
AI-Assisted Screening
Claude evaluates every abstract against your inclusion and exclusion criteria. Returns INCLUDE / EXCLUDE / UNCERTAIN with a one-sentence rationale. You confirm or override — every decision is logged.
Structured Data Extraction
Define your extraction schema once. AI fills every field and cites the exact sentence from the paper. Reviewers confirm field by field. Exports to CSV the moment you're done.
Risk of Bias Assessment
Pre-fills RoB 2.0 (RCTs) and ROBINS-I (observational studies) domain by domain with supporting quotes from the full text. Traffic light summary table auto-generates across all included studies.
The Full Systematic Review Workflow
One platform from search strategy to PRISMA diagram. No spreadsheets, no tool-switching, no lost audit trail.
01
Search Strategy
Log databases, boolean strings, and records found. Feeds PRISMA counts automatically.
02
Reference Import
Drag-and-drop RIS or CSV. Automatic deduplication by DOI and normalized title.
03
AI Screening
Abstract-level pre-screening with INCLUDE / EXCLUDE / UNCERTAIN. Keyboard or swipe on mobile.
04
Extraction & RoB
Schema-defined data extraction with source citations. RoB 2.0 and ROBINS-I pre-fill.
05
Export & Report
PRISMA 2020 SVG, extracted data CSV, screening log, audit trail. Submission-ready.
Built for Rigorous Review Teams
Designed for buyers who know what Cohen's kappa is and why it matters.
Pharmaceutical evidence teams
Safety reviews, label updates, HTA submissions. Defensible methodology with a full audit trail your regulatory team can stand behind. Your data stays yours — always.
HTA agencies
NICE, CADTH, ICER, and equivalent bodies. Tools that match the methodological standards you already apply to the evidence you receive.
Systematic review consultancies
Firms producing reviews for pharma, HTA agencies, and guideline bodies. Run more reviews at higher margin without adding headcount.
Academic research groups
Well-funded groups doing 5–20 reviews a year. Spend your time on judgment calls, not spreadsheet maintenance.
How Rigora Compares
Covidence and Rayyan are widely used. Here is where each one stops — and where Rigora starts.
| Feature | Rigora | Covidence | Rayyan |
|---|---|---|---|
| Starting price | Free | $339 / review | Free (3 reviews) |
| Full workflow — screening through export | |||
| AI-native extraction with source citations | |||
| Your data belongs to you | IP risk | ||
| PRISMA 2020 flow diagram | |||
| RoB 2.0 / ROBINS-I | |||
| Full audit trail | |||
| Living review support | |||
| Network meta-analysis |
Rayyan's Terms of Service (§7) grant a perpetual, royalty-free license to use all content you upload — including screening decisions and extracted data. For proprietary pharma evidence, this is a material data governance risk. Covidence pricing as of 2025.
Journal Readiness Built In
Every requirement tracked in real time. No checklist archaeology at submission.
Simple, Transparent Pricing
A full systematic review costs $50,000–$250,000 in researcher hours. Rigora compresses that by 60–80%. The math is straightforward.
See full pricing — Institutional, LMIC ($15/month), and annual plans →
Start with one review. No credit card required.
The free tier supports a full review end-to-end — up to 200 references. Every AI feature included. See how it works before you commit.
Questions? hello@rigora.com